|
Volumn 20, Issue 4, 2002, Pages 473-479
|
Phase I trial of edatrexate in advanced breast and other cancers
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EDATREXATE;
ADULT;
ADVANCED CANCER;
AGED;
ALOPECIA;
ANEMIA;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BREAST CANCER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONSTIPATION;
CRYOTHERAPY;
DIARRHEA;
DOSE RESPONSE;
ERYTHEMA;
FATIGUE;
FEMALE;
HEARTBURN;
HUMAN;
INFECTION;
LEUKOCYTOSIS;
LEUKOPENIA;
MAXIMUM TOLERATED DOSE;
METASTASIS;
MUCOSA INFLAMMATION;
NAUSEA;
NEUROLOGIC DISEASE;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
RASH;
THROMBOCYTOPENIA;
VOMITING;
ADULT;
AGED;
AGED, 80 AND OVER;
AMINOPTERIN;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
KARNOFSKY PERFORMANCE STATUS;
LUNG NEOPLASMS;
MAXIMUM TOLERATED DOSE;
MELANOMA;
MENOPAUSE;
MIDDLE AGED;
RECEPTORS, ESTROGEN;
RECEPTORS, PROGESTERONE;
TREATMENT OUTCOME;
|
EID: 0036290912
PISSN: 07357907
EISSN: None
Source Type: Journal
DOI: 10.1081/CNV-120002147 Document Type: Article |
Times cited : (8)
|
References (8)
|